Stallion India shifts Oct 1 analyst meet to in-person format
- Stallion India Fluorochemicals shifted its Oct 1 analyst meeting to an in-person format
- Previous plan for a group virtual session was replaced by individual meetings
- Participants include Aditya Birla Sun Life MF, OHM Capital, and Ambit Asset Management
- No unpublished price sensitive information will be discussed during the sessions

*this image is generated using AI for illustrative purposes only.
Stallion India Fluorochemicals has revised the format of its scheduled analyst and investor meeting for Thursday, October 1, 2026. The company will now conduct individual in-person meetings instead of the previously announced group virtual session.
The management team will engage with key institutional stakeholders to discuss company updates. This revision was communicated pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with Part A of Schedule III to the SEBI Listing Regulations.
Revised meeting schedule
The company confirmed the participation of three specific asset management and investment firms. The mode of interaction has changed from virtual to in-person, with specific time slots allocated for each participant.
| Participant | Time (IST) | Mode |
|---|---|---|
| Aditya Birla Sun Life Mutual Fund | 3:30 pm | In-person |
| OHM Capital | 4:40 pm | In-person |
| Ambit Asset Management | 5:30 pm | In-person |
Compliance and disclosure
The company stated that no unpublished price sensitive information (UPSI) will be discussed during the meetings. The schedule remains subject to change due to exigencies on the part of the company or the concerned analysts and investors. Any changes in the schedule will be intimated to the stock exchanges where required.
The communication regarding the revised schedule was signed by Govind Rao, Company Secretary & Compliance Officer, on September 29, 2026.
Historical Stock Returns for Stallion India Fluorochemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.05% | -6.88% | -6.62% | +49.27% | -37.73% | +66.82% |
How might the shift to in-person meetings influence the depth of due diligence conducted by Aditya Birla Sun Life, OHM Capital, and Ambit Asset Management?
What specific strategic updates or capacity expansion plans is Stallion India Fluorochemicals expected to disclose to these key institutional investors?
Could the preference for individual in-person engagements signal a broader trend among Indian mid-cap chemical firms seeking more controlled investor relations environments?


































